9/30/2022  5:29:56 PM Chg. +12.00 Volume Bid5:29:56 PM Ask5:29:56 PM Market Capitalization Dividend Y. P/E Ratio
1,237.50SEK +0.98% 428,401
Turnover: 527.98 mill.
1,235.50Bid Size: 264 1,236.50Ask Size: 434 1895.39 bill.SEK - -

Business description

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Management board & Supervisory board

Pascal Soriot
Management board
Aradhana Sarin, David Fredrickson, Iskra Reic, Jeff Pott, Katarina Ageborg, Leon Wang, Marc Dunoyer, Menelas Pangalos, Pam Cheng, Ruud Dobber, Susan Galbraith
Supervisory board
Leif Johannson, Andreas Rummelt, Aradhana Sarin, Deborah DiSanzo, Diana Layfield, Euan Ashley, Marcus Wallenberg, Michel Demaré, Nazneen Rahman, Pascal Soriot, Philip Broadley, Sheri McCoy, Tony Mok

Company data

Name: AstraZeneca plc
Address: 2 Kingdom Street,UK-London W2 6BD
Phone: +44-20-7604-8000
Fax: +44-20-7604-8151
E-mail: -
Internet: www.astrazeneca.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 77.64%
IPO date: -

Investor relations

Name: Chris Sheldon
IR phone: +44-203-749-5712
IR Fax: -
IR e-mail: IR@astrazeneca.com

Company calendar

CW 46 | 11/10/2022 Interim Report 1st Quarter/3 Months

Main Shareholders

BlackRock, Inc.
Wellington Management Group LLP
Wellington Management Company LLP
The Capital Group Companies, Inc.
Investor AB